🇺🇸 FDA
Pipeline program

BW-20805 Injection

BW-20805-2001

Phase 2 small_molecule active

Quick answer

BW-20805 Injection for Hereditary Angioedema is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Hereditary Angioedema
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials